About Bio-Thera Solutions, Company

The company was officially listed and traded on the Science and Technology Innovation Board of the Shanghai Stock Exchange in February 2020. Under the leadership of the company's technical management team, it has successfully broken through a series of key technologies and established a rich product pipeline in the fields of oncology, autoimmune diseases, cardiovascular diseases, ophthalmology, etc. The company is an innovative biopharmaceutical enterprise with research and development of innovative drugs and biosimilar drugs as the core. Its main business is drug R&D, production and sales, and it has an independent and complete R&D, procurement, production and commercialization system. Major products: Galeride, Prerich, Schrelli, and Betanin. Corporate honors: Guangdong Antibody Drug Coupling Biomedical Engineering Laboratory (Guangdong Engineering Laboratory), Guangdong PhD Workstation, R&D facility construction of Baiaotai Biotechnology (Guangzhou) Co., Ltd., “Most Promising Company” for venture capital in Hong Kong, etc.